Immune modulation in the treatment of respiratory infection.
The limitations of currently available treatment for severe respiratory infection are demonstrated by the relatively fixed mortality associated with these infections despite advances in nutrition, vaccines, antibiotics, and critical care. This might be due in part to the changing spectrum of pathogens and development of drug resistance. Cytokines are potent molecules that function as growth factors and orchestrate both innate and adaptive immune responses. Several of these factors have entered the clinical arena to support or augment the immune response. Moreover, the use of cytokines has recently been expanded to patients without an overtly defective immune system but who have either significant infection or infection with drug resistant organisms. The use of cytokines as adjuvants in the treatment of respiratory infections is reviewed.
Kolls
J K
JK
Department of Medicine, LSU Health Sciences Center, New Orleans, Louisiana 70112-1393, USA. jkolls@lsumc.edu
Nelson
S
S
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D016207:Cytokines / Q000627:therapeutic use*; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D016207:Cytokines